News Health/Medical The Ecig Summit: Insights and Trends
0
Smoking cessation

Published :

The Ecig Summit: Insights and Trends

By Derek Yach

May 15, 2024

What did we learn from the Ecig Summit in Washington, DC? Let's delve into the key takeaways that shed light on tobacco harm reduction (THR) products and their impact on smoking cessation.

Changing Perspectives on THR

In recent months, leading medical journals have highlighted the benefits of vaping for smoking cessation[^1^][1]. Academics, who rarely agree on THR policies, are increasingly calling for medically licensed vapes. However, the exclusion of industry scientists from presenting research at the Summit poses challenges to achieving diverse perspectives.

Global Realities and Future Trends

While smoking and vaping prevalence among youth has declined in the United States, smoking rates remain high among certain demographics. Looking globally, smoking rates in many Middle Eastern, Eastern European, and Asian countries exceed those seen in the U.S. decades ago. THR provides an opportunity to leapfrog over this road taken by the USA. Additionally, smokeless tobacco products are prevalent in South Asia and contribute to oral cancer deaths. Nicotine pouches could be a viable solution to combat this dreadful cancer worldwide.

Addressing Adult Smokers and Early Disease

Summits have often focused on youth, but it's crucial to strike a balance between addressing the needs of adults who smoke and those with early-stage disease. Former FDA heads and influential academics emphasize the importance of harm reduction endpoints in drug approvals[^1^][1].

Let's continue the conversation on THR and explore innovative solutions to end combustible tobacco use.

  • Reactions

    0
    0
    0
    0
    0
    0

    Your email address will not be published. Required fields are marked *